NCT04850144View on ClinicalTrials.gov

Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler®

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

April 26, 2021

Primary Completion Date

October 4, 2021

Study Completion Date

October 4, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

Tiotropium Bromide Monohydrate

Tiotropium Easyhaler 10 µg/dose Product variant D

DRUG

Tiotropium Bromide Monohydrate

Tiotropium Easyhaler 10 µg/dose Product variant E

DRUG

Tiotropium Bromide Monohydrate

Tiotropium Easyhaler 10 µg/dose Product variant F

DRUG

Tiotropium Bromide Monohydrate

Tiotropium Easyhaler 10 µg/dose Product variant G

DRUG

Tiotropium Bromide Monohydrate

Tiotropium Easyhaler 10 µg/dose Product variant H

DRUG

Tiotropium Bromide Monohydrate

Spiriva 18 µg/capsule inhaled via Handihaler

DRUG

Tiotropium Easyhaler with oral activated charcoal

The charcoal suspension will be administered orally with Tiotropium Easyhaler 10 µg/dose Product variant F

Trial Locations (1)

Unknown

Clinical Pharmacology Unit, Orion Corporation, Espoo

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY